<?xml version="1.0" encoding="UTF-8"?>
<p>Since viral PLPs are used by coronaviruses to both replicate and to antagonize the innate immune response, they are considered important therapeutic targets for coronavirus infections and thus may be of interest for future COVID-19 treatment strategies. In this review, we report an up-to-date description of coronaviral PLPs functions and their inhibitors, and provide possible therapeutic strategies for COVID-19 treatment, using both clinically approved and preclinical drugs.</p>
